Overview

Aspirin in Young Psychotic Patients

Status:
Completed
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
In this double blind randomized clinical trial the investigators are going to exam influence of adjuvant Aspirin therapy on soft neurological signs (Heidelberg scale), positive and negative symptoms (PANSS), cytokine profile and inflammatory factors, as well as on cognition (MoCA) in young psychotic patients.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Clinic for Psychiatric Disorders, Dr Laza Lazarevic
Collaborator:
Stanley Medical Research Institute
Treatments:
Aspirin
Pantoprazole